IP Library Granted Patent US 6,845,328
Granted Patent B2
US 6,845,328 · App. 09/998,805 · Granted Jan 18, 2005

Screening methods using the crystal structure of ribosomal protein L11/GTPase activating region rRNA complex

Assignee: University of Utah Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,845,328
App. No.
09/998,805
Granted
Jan 18, 2005
Kind
B2
Abstract

The present invention is broadly directed to methods of screening ribosomal protein L11/GTPase activating region (GAR) RNA-modulating compounds by using information from the high-resolution structure of the L11/GAR complex. The methods are useful in identifying compounds useful for anti-bacterial treatments.

Claims (12)

1. A method for identifying a potential modulator of ribosomal protein L11/GAR activity, comprising the steps of:

a) providing the atomic co-ordinates of the L11 GTPase Activating Region (L11/GAR) in Table II, thereby defining a three-dimensional structure of the L11/GAR;

b) using said three dimensional structure of the L11/GAR to design or select a potential modulator by computer modeling;

c) providing said potential modulator; and

d) physically contacting said potential modulator with L11/GAR to determine the ability of said potential modulator to modulate L11/GAR activity, wherein a modulator of L11/GAR activity is identified.

2. The method according to claim 1 , wherein said potential modulator is designed de novo.

3. The method according to claim 1 , wherein said potential modulator is designed from a known modulator.

4. The method according to claim 1 , wherein said step of employing said three-dimensional structure to design or select said potential modulator comprises the steps of:

a) identifying chemical entities or fragments with the potential to bind said L11/GAR; and

b) assembling the identified chemical entities or fragments into a single molecule to provide the structure of said potential modulator.

5. The method according to claim 4 , wherein said potential modulator is designed de novo.

6. The method according to claim 4 , wherein said potential modulator is designed from a known modulator.

Assignments (7)
CONFIRMATORY LICENSE Recorded Jan 29, 2018
From: UNIVERSITY OF UTAH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045180/0933 →
CONFIRMATORY LICENSE Recorded Jan 25, 2018
From: UNIVERSITY OF UTAH
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 044729/0203 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2004
From: WIMBERLY, BRIAN T.; RAMAKRISHNAN, VENKATRAMAN
To: UNIVERSITY OF UTAH
Reel/Frame 015473/0427 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2004
From: CARNEY, JAYNE
To: UNIVERSITY OF UTAH RESEARCH FOUNDATION
Reel/Frame 015080/0216 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2004
From: WIMBERLY, BRIAN T.; RAMAKRISHNAN, VENKATRAMAN
To: UNIVERSITY OF UTAH
Reel/Frame 015085/0677 →
CHANGE OF NAME Recorded Dec 4, 2003
From: RIBOTARGETS LIMITED
To: VERNALIS (CAMBRIDGE) LIMITED
Reel/Frame 014786/0636 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 1998
From: VINCENT, ALAIN; RESLINGER, MICHEL; GODARD, GERARD; LAURENCY, PHILIPPE
To: ALCATEL ALSTHOM COMPAGNIE GENERALE D'ELECTRICITE
Reel/Frame 009285/0825 →
Continuity (3)
Continuation PCTUS001201900 · May 3, 2002
Provisional Application 6013417100 · May 13, 1999
Related Publication 20030099955A1 · May 29, 2003